Caplin Point Laboratories Ltd.

BSE: 524742 | NSE: CAPLIPOINT |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE475E01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Caplin Point L Caplin Point Laboratories Ltd. | BSE 2033.40 3.25 (0.16%) | NSE 2032.80 2.30 (0.11%) | Trade | Add

BSE Live

Oct 31, 16:01

2033.40 3.25 (0.16%)

Volume

AVERAGE VOLUME

5-Day

3,516

10-Day

3,752

30-Day

6,247

1,678

Prev. Close

2030.15
Open Price

2031.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 31, 15:59

2032.80 2.30 (0.11%)

Volume

AVERAGE VOLUME

5-Day

30,391

10-Day

36,703

30-Day

77,701

43,860

Prev. Close

2030.50
Open Price

2036.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2032.80 (2)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Caplin Point Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,921.23	1,676.78	1,453.82	1,263.01	1,048.26
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	1,921.23	1,676.78	1,453.82	1,263.01	1,048.26
Total Operating Revenues	1,937.47	1,694.10	1,466.73	1,269.41	1,061.29
Other Income	96.43	66.94	55.98	38.75	23.54
Total Revenue	2,033.90	1,761.04	1,522.71	1,308.16	1,084.83
EXPENSES
Cost Of Materials Consumed	248.45	239.81	206.28	192.31	129.82
Purchase Of Stock-In Trade	483.83	558.92	503.87	397.12	259.57
Operating And Direct Expenses	0.00	0.00	0.00	0.00	3.36
Changes In Inventories Of FGWIP And Stock In Trade	38.56	-74.55	-46.94	-31.92	82.35
Employee Benefit Expenses	177.72	143.59	136.99	115.30	102.53
Finance Costs	0.61	0.78	0.78	0.70	1.59
Depreciation And Amortisation Expenses	65.96	53.44	44.99	46.90	36.97
Other Expenses	341.98	274.89	225.47	201.93	155.02
Total Expenses	1,357.11	1,196.88	1,071.44	922.34	771.21
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	676.79	564.16	451.27	385.82	313.62
Exceptional Items	-0.01	0.27	0.08	0.00	0.00
Profit/Loss Before Tax	676.78	564.43	451.35	385.82	313.62
Tax Expenses-Continued Operations
Current Tax	125.33	101.55	82.09	83.91	71.14
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	10.36	1.46	-7.73	-6.54	-8.96
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	135.69	103.01	74.36	77.37	62.19
Profit/Loss After Tax And Before ExtraOrdinary Items	541.09	461.42	376.99	308.45	251.43
Profit/Loss From Continuing Operations	541.09	461.42	376.99	308.45	251.43
Profit/Loss For The Period	541.09	461.42	376.99	308.45	251.43
Minority Interest	-4.78	-4.33	-0.73	-8.61	-9.16
Consolidated Profit/Loss After MI And Associates	536.31	457.09	376.26	299.84	242.27
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	71.00	60.00	50.00	40.00	32.00
Diluted EPS (Rs.)	70.00	60.00	49.00	39.00	32.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	34.17	30.32	0.00	3.03
Tax On Dividend	0.00	0.00	0.00	0.00	0.00